BridgeMD
New treatment option for Obsessive-Compulsive Disorder
Official title Interpretation Bias as a Mechanism of Treatment Response in OCD
ClinicalTrials.gov ID: NCT05224414
What this study is testing
- What it's testing
- This study will conduct a randomized controlled trial of Cognitive Bias Modification for Interpretation (CBM-I) as an augmentation to treatment as usual for obsessive compulsive disorder (OCD). CBM-I is a digital intervention designed to directly manipulate interpretation bias through repeated practice on a training task, thereby inducing cognitive changes in a relatively automatic or implicit manner.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 1) OCD Institute patients
- 2) adults (\> 18 years old)
- 3) able to complete a computer task for 20 minutes
- 4) consent to main OCD Institute study protocol
- 5) primary diagnosis of OCD (as measured by a score of \>16 on the Y-BOCS and a clinical diagnosis of OCD by their treatment team
You likely can't join if
- 1) Currently experiencing acute symptoms of psychosis
- 2) Psychotic disorder diagnosis
See the full eligibility criteria
- 1) OCD Institute patients
- 2) adults (\> 18 years old)
- 3) able to complete a computer task for 20 minutes
- 4) consent to main OCD Institute study protocol
- 5) primary diagnosis of OCD (as measured by a score of \>16 on the Y-BOCS and a clinical diagnosis of OCD by their treatment team
- 6) score of \>131 on the Obsessive Beliefs Questionnaire-44 at admission [which is 1 SD above the mean score of the non-clinical sample reported in the original validation paper by the Obsessive Compulsive Cognitions...
- 1) Currently experiencing acute symptoms of psychosis
- 2) Psychotic disorder diagnosis
The study team makes the final eligibility decision.
Where it's taking place
- Belmont, Massachusetts, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Belmont, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.